Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Patrick Cunningham
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 75on tracked calls
- Challenge rate
- 9%7 of 75 questions
- Companies
- 11questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 75 of 75 questions from 11 companies
APDAir Products13 questions · 8 reporting periods · 2 of 13 challenging
Calendar 2026 Q2
you said that you were able to monetize something about $1 billion, I think. I'm just wondering if that still holds true
Show response
Eduardo said prior Darrow monetization figures were estimates and declined a clear timeline, emphasizing value comes from selling the units as a whole; on Edmonton he offered no updates on start-up dates or costs.
Calendar 2026 Q1
could you provide an update on the Alberta project in terms of offtakes timing and any update to costs?
Show response
Eduardo offered minimal detail. No updates on offtakes or costs. Working with Canadian federal and provincial governments on regulatory conditions.
If the supply disruption persists, would you need to put customers on allocation? How long does it take alternative supply sources
Show response
Eduardo noted Qatar supply was already offline since December so conflict did not materially change the supply situation. Company has enough product for customers.
Calendar 2025 Q4
Is there any dependency on the relationship with Yara at Darrow. And are these go, no go decisions being viewed separately?
Show response
Eduardo confirmed NEOM and Louisiana negotiations are independent. NEOM product is green with zero CBAM impact. Any CBAM changes would only have indirect market effects.
should we expect that to be at a loss when the asset first ramps up given the debt profile and initial fixed cost burden?
Show response
Management confirmed NEOM JV will not start at a loss but declined to disclose specific expected equity affiliate contributions from the 33%-owned venture.
Calendar 2025 Q3
Can you provide some color on what was driving that and what we should sort of expect for step up or step down across all of the regions and equity income next year?
Show response
Melissa attributed Americas growth to Mexican JV (expected flat in FY2026). Jazan JV declined in FY2025 but expected to pick up in FY2026 as interest rates decline.
If you decide to forgo downstream investment in NEOM maybe based on unfavorable regulatory environment, whatever it may be, what do the commercial options look like?
Show response
Eduardo acknowledged initial sales will be as ammonia with green premium percentage growing over time. Full 2027 forecast not available yet given ammonia market pricing dynamics.
Calendar 2025 Q2
Does this change the dynamic at all for Air Products? I know you mentioned Darrow is cost competitive, but are there now fewer logical equity partners
Show response
Eduardo sees room for APD's project alongside competitors, noting increasing clean ammonia demand from Far East power producers and European market potential.
Calendar 2025 Q1
you're now delaying the downstream investment until you get regulatory clarity - what does that mean for the agreement with Total?
Show response
Eduardo clarified Total agreement is for 2030, with ongoing engineering and permitting work. By 2027, expects definition on which refinery to supply based on country-level EU regulation transposition.
What's your sense for the opportunity on productivity and price optimization for the core business? How meaningful will those levers be?
Show response
Eduardo expressed confidence in raising operating margins to 30% through blocking and tackling, noting base business at 24% with room for improvement.
Calendar 2024 Q4
I'm just wondering what your latest thoughts are there. Any conversations with customers suggesting this could be maybe a short-term negative to production
Show response
Melissa framed tariff risk as moderate for projects, minimal for core business given local production model, with main risk being macro knock-on effects to customers.
Calendar 2024 Q3
with the LNG out of the business, what should we expect in terms of the corporate line for 2025?
Show response
Melissa quantified LNG headwind precisely at $0.49 EPS or 4%, distributed evenly across quarters.
could you provide a more general update on the World Energy Project? What is holding up the permitting process?
Show response
Seifi explained permit was challenged by environmental groups despite being an environmentally friendly project. Decision to wait for full permits before proceeding.
DDDuPont9 questions · 5 reporting periods · 0 of 9 challenging
Calendar 2026 Q2
can you just expand maybe on which parts of the portfolio is maybe accelerating higher than others?
Show response
Franzen detailed Building Tech up low-single-digit and Industrial Tech mid-single-digit with an improving order book.
Calendar 2026 Q1
You previously noted, I think, free cash flow greater than 90% for 2026. Is that still the case?
Show response
Franzen confirmed >90% FCF conversion target intact. Q1 conversion was 65%, consistent with normal H1/H2 cadence (interest payments in Q2/Q4). Teams managing inventory days down YoY despite higher input costs. DSO collections also a focus.
I think this is the first time you kind of explicitly called out microelectronics within water
Show response
Koch confirmed microelectronics is ~20% of ion exchange business within water. Seeing nice volume growth in Q1 driven by broader data center trend.
Calendar 2025 Q2
we should expect less of a drag from price in the second half?
Show response
Franzen confirmed price decline moderating as inflationary-era concessions are lapped, with volume-price trade-offs managed at line-of-business level.
Can you help us think about the margin progression for the second half given you've lapped the bulk of destocking
Show response
Franzen quantified 100bps underlying margin expansion (70bps reported) with IndustrialsCo incrementals at ~70% driven by productivity.
Calendar 2025 Q1
do you see any pressure on that outperformance, whether it's additional competitive dynamics, or changes with customer relationships
Show response
Kemp argued competitive moat from application engineering support and quality requirements as process complexity increases.
could fresh restrictions be a potential retaliatory measure in this trade environment?
Show response
Kemp acknowledged the possibility but noted no specific anticipated restrictions, citing DuPont's track record of navigating since 2019.
Calendar 2024 Q4
is there any update on Kalrez? How is that business performing? We had a few quarters of sharp destocking
Show response
Koch directly identified Kalrez as the last business still in destocking, targeting mid-2025 for normalization.
would you characterize these as normal levels? And does it change maybe what the long-term margin target would be for the IndustrialsCo versus W&P?
Show response
Koch acknowledged retained businesses have high-teens to low-20s margins, below heritage W&P levels, with more detail deferred to Investor Day.
ALBAlbemarle Corporation7 questions · 4 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
curious to hear kind of your latest thoughts on the supply side of the equation
Show response
Kent said demand is running ahead of supply, keeping the market tight, but current roughly $20/kg pricing is not driving speculative new projects.
Calendar 2026 Q1
you seem to hint the broader deployment of renewables as a result of the crisis could be a potential positive for lithium demand. I guess, is that anything that you've seen already?
Show response
Masters said energy security and grid resiliency are bigger drivers globally. Difficult to attribute incremental demand directly to the Middle East crisis, but it may impact both EVs and energy storage.
one of your JV partners noted some issues around grade recoveries and production stability, maybe even suggesting that they're more systemic. I guess, is this in line with your assessment?
Show response
Masters said the mine is on plan including CGP3 ramp. They risk-adjust annual forecasts across all assets. CGP3 started up end of 2025 and the ramp is on schedule.
Calendar 2025 Q3
How have sort of the bromine supply and demand trended throughout the balance of the year?
Show response
Norris described mixed bromine demand with electronics/pharma strong but construction/oil-gas weak. Market is fairly balanced heading into year-end.
anything else you're looking at in terms of productivity savings program into next year? And what would be the size of sort of the incremental carryover?
Show response
Sheorey noted partial-year savings from 2025 will roll into 2026 with full-year benefit. Plant ramps like Meishan (a year ahead of schedule) provide ongoing productivity.
Calendar 2024 Q4
That remaining 50% piece not on long-term agreements, should we assume most of those follow spot mechanisms?
Show response
Masters confirmed the non-floor 50% is essentially at spot/index pricing and noted no recent renegotiations of floor contracts.
where are you cutting back investments in resources? And given the current program, how quickly can you repossession and invest in additional brownfield
Show response
Masters clarified most CapEx cuts were in conversion, not resources. Acknowledged growth rates will slow after 2027, mostly due to resource constraints.
LYBLyondellBasell7 questions · 7 reporting periods · 2 of 7 challenging
Calendar 2026 Q2
I wanted to dig into a little bit more on supply disruption. I think the ability for China to sell out of inventory
Show response
Vanacker said China structurally adapted (more coal-to-olefins, higher exports) but that the inventory drawdowns are temporary and China should return to importing.
Calendar 2026 Q1
if you could walk through any of the structural changes you've seen from a cost curve and supply and demand standpoint given the conflict
Show response
Aaron detailed pricing power across all I&D products: methanol doubled from $300 to $600/ton in 3 months, acid pricing up 50%, VAM up 100%. US natural gas pricing lowest across all regions giving cost advantage. Both PO technologies in first quartile of cost curve. Running 75% Q2 utilization due to Bayport outage, expects 95-100% once Bayport returns.
Calendar 2025 Q4
if the reduced CapEx guide is a function of just recent asset sales or if there's a change in your maintenance CapEx or if the new $800 million on maintenance is the normal baseline
Show response
Peter explained $800M maintenance CapEx is not the new normal, historical sustaining CapEx was $1.2B, expected to settle at ~$1.1B post-European asset sale. Only 2 turnarounds in 2026 vs typical 3-4 per year. Years of above-depreciation investment enable lighter 2026 spending. Agustin confirmed light turnaround year with only Midwest and smaller IND turnaround.
Calendar 2025 Q3
how would you weight the likelihood of any sort of inflection point in supply and demand or underlying prices and margins into next year
Show response
Peter cited 21M tonnes of ethylene capacity expected to close, noting much Chinese capacity is on wrong side of cash cost curve. Emphasized need to look at economically feasible capacity, not just nameplate. Kim added new derivative capacity coming online will tighten ethylene markets and improve chain margins into 2026. Peter noted oil-to-gas ratio would need to fall to 6-7x to flatten cost curve; sees 12-15% range ahead.
Calendar 2025 Q2
what sort of sequential lift should we be triangulating based on current visibility? And does anything in your view, support additional price increases that are out in the market
Show response
Peter quantified $85M sequential tailwind from Channelview turnaround completion. Guided 85% segment utilization for Q3. Kim added that back-to-back PE price increases are historically unusual without supply disruption, but cited several positive indicators: improving exports, domestic demand up YoY/QoQ/MoM, low global inventories, and hurricane season risk.
Calendar 2025 Q1
why is now the right time to proceed? And would you consider delaying if negative conditions persist
Show response
Peter defended Flex-2 timing citing mid-teens IRR. VEP and cash improvement plan enable continued strategic investment. Committed that 2026 CapEx will not be substantially higher than 2025 levels. Strategy confirmed even in volatile environment.
Calendar 2024 Q4
sitting with plenty of supply overhang across a number of chains, sluggish demand, does anything suggest this is the new normal
Show response
Peter acknowledged structural shifts moderating future mid-cycle margins but pointed to demand recovery signs. Cited PE domestic demand +4% and overall +8% YoY. Did not directly address whether current margins are the new normal.
SHWThe Sherwin-Williams Company7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
give a little bit of detail behind the drivers for both the commercial and protective segments.
Show response
Jaye credited two years of targeted commercial share work and named data centers, semiconductor fabs, water treatment and pharma as Protective drivers.
Calendar 2026 Q1
Have you seen any evidence of weakness quarter to date in order books
Show response
Heidi said no material order shift. Ben noted 60-90 day feedstock gap from Middle East could squeeze Asia and Europe supply later, potentially impacting demand as costs rise.
Calendar 2025 Q4
given the recent mega merger announcement, there's potentially some fresh disruption.
Show response
Heidi cited SHW's stable strategy and execution playbook as a competitive advantage during industry disruption; teams will be aggressive.
Calendar 2025 Q3
Can you help square the negative operating leverage despite the positive sales? Maybe just some color around the mix drag
Show response
Al attributed PCG margin decline to unfavorable region/business mix; Europe acquisitions dilutive, Latin America down; Q4 expected to see moderation.
Calendar 2025 Q2
Can you comment on how underlying backlogs and activity, you know, evolved throughout the balance of the quarter and into July.
Show response
Heidi said res repaint backlogs are stable with marginal bid activity increase; project sizes getting smaller; SHW working with contractors to find new opportunities and positioned to win when market recovers.
Calendar 2025 Q1
Just on the continued strength in res repay, can you comment on underlying market trends, backlogs and any concerns with pressure on the consumer
Show response
Heidi characterized res repaint backlogs as positive with smaller project sizes; SHW investing in SG&A ahead of the curve to capture share; labor/immigration not a concern given value prop focused on productivity.
Calendar 2024 Q4
I'm curious on the latest thoughts on the M&A pipeline.
Show response
Heidi described M&A as a consistent steady-hand approach, always looking for technology/brand/region opportunities but not dependent on it for growth; will evaluate attractive opportunities that fit strategy.
CTVACorteva6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
How should we think about your normalized free cash flow levels maybe next year
Show response
Johnson said ex-unusual items free cash flow conversion would be around 46%, within the 45-50% of EBITDA midterm target.
Calendar 2026 Q1
What is the target percentage for this mix by the end of the decade?
Show response
Robert King noted portfolio is roughly two-thirds differentiated with new CP products pushing $2B in revenue. Rinskor, Aviso for Asian soybean rust, and biologicals will drive further mix improvement. Did not directly address patent cliffs.
Calendar 2025 Q4
does the current channel inventory position support a return to more normalized purchasing patterns?
Show response
Robert said channels about normal for time of year. Expecting continued volume growth in LatAm with more land in production but pricing pressures to persist. Farmers stressed with high interest rates and suppressed commodity prices but still making money. Barter program near $1B in combined crop and seed revenue to mitigate risk.
Calendar 2025 Q3
Could you provide an update on hybrid wheat or double cropping systems
Show response
Chuck confirmed 2027 hybrid wheat launch on track. Seeing 10-15% consistent yield improvement in year 3 of trials. $1B peak revenue potential. Margin profile expected similar to corn/soybeans.
Calendar 2025 Q2
how sizable has that benefit been in the first half of '25? And should that still be a sizable benefit in 2026
Show response
David said slightly ahead on seed net cost improvement. Commodity impact runs through P&L over 2-3 year period via hedges and inventory. $700M 3-year target tracking well.
Calendar 2025 Q1
Seed production costs were solidly lower in the quarter and just want to understand the extent of commodity cost inflation hitting the P&L versus execution on productivity
Show response
Judd said $100M cost benefit in Q1 split between commodity and productivity. David confirmed $200M seed and $200M CP for full year, with H1 somewhat front-loaded due to deflation timing.
Show 5 more companies
ECLEcolab6 questions · 6 reporting periods · 1 of 6 challenging
Calendar 2026 Q2
can you share details on what is contributing to the increased traction there? And how much acceleration do you expect
Show response
Beck credited the One Ecolab cross-sell of food safety into water customers and vice versa, noting F&B sits at the top of its 5% to 7% long-term target range with global rollout still ahead.
Calendar 2026 Q1
is most of your growth coming from deeper penetration of digital suites and productivity tools
Show response
Beck confirmed digital-led growth in Specialty at 9%. Emphasized wherever the consumer goes, Ecolab captures them across luxury, mid-scale, or quick-serve.
Calendar 2025 Q4
you maybe give us an update on how your ability to monetize these technologies has evolved in 2025
Show response
Beck described Ecolab Digital at ~$400M growing 20%+ in 2025, expects ~25% growth in 2026. Vision is 100-1-100: 100% locations connected, 100% applications, 100% billable. Many customers using technology but not yet paying. Low single-digit penetration with millions of potential customers.
Calendar 2025 Q3
How should we think about SG&A leverage, particularly in Pest and Life Sciences, next year as you start to lap some of the growth investments you've made across both businesses?
Show response
Kirkland reported 150bps SG&A leverage since 2019, expects 20-30bps in FY2025. Beyond 2025, expects 25-50bps annual SG&A leverage from One Ecolab savings and technology deployment. Beck highlighted AI agents driving productivity.
Calendar 2025 Q2
I think you cited supply chain costs and unfavorable mix. But I think our assumption was some of these faster-growing markets have better mix. So what was the source of that unfavorable mix?
Show response
Kirkland attributed all Water OI drag to basic industries and paper. Ex those businesses, Water grew 4% with strong double-digit OI growth.
Calendar 2025 Q1
What sort of growth rates and margin accretion are you anticipating?
Show response
Beck declined to disclose margin yet but noted very high margins given digital nature. Software growing faster than hardware. 100K connected of 1M+ potential.
LINLinde plc6 questions · 5 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
is the bulk of that inflection that you have seen coming from commercial space?
Show response
Sanjiv gave a detailed second-half end-market outlook, citing 18% electronics growth, robust manufacturing, and spottier chemicals/energy.
Calendar 2026 Q1
it seems like there's probably a heightened focus on energy security, deglobalization -- so I'm curious as how you're thinking about the potential
Show response
White said renewables still require government support to accelerate. Traditional hydrocarbons like Canadian oil sands getting renewed interest given lower exploration risk. Expects more LNG development in stable geographies.
how should we think about on-site volumes and potential earnings upside for the balance of the year
Show response
White acknowledged some assets running well but production shifting to Americas. European recovery needs a catalyst, either import restrictions or IAA spending reaching the ground. Hard to see major shift without policy change.
Calendar 2025 Q4
on the 90 new customer wins in oxyfuel combustion, can you just help us understand the specific customer base
Show response
Sanjiv highlighted oxyfuel wins globally with China disproportionately high. Technology helps customers reduce emissions, lower natural gas consumption, and increase throughput. Business development momentum playing out with wins under execution.
Calendar 2025 Q3
it seems like we've lapped some of the tariff concerns, you started to see some uptick here
Show response
Sanjiv detailed US package: mid-single digit organic growth, gas volumes down low single digit (helium drag), hard goods up mid-single digit from automation/equipment. Customer sentiment cautious on major CapEx but volumes resilient.
Calendar 2024 Q4
Just on the step-up in CapEx for 2025, is most of that being driven by the two large projects?
Show response
Sanjiv confirmed backlog driving CapEx step-up including two large clean energy projects and electronics projects.
PPGPPG Industries6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q1
you mentioned closing 4 manufacturing plants in the second half. Could you quantify the fixed cost savings there
Show response
Knavish: 4 plant closures yield approximately $25 million annual fixed cost reduction starting 2027 in perpetuity. Total company restructuring benefits about $50 million in 2026 and another $50 million in 2027 including back-office and formula optimization. Arch EMEA mission: deliver good earnings and cash at flat volumes to fund higher-growth businesses. Had a good March. Not waiting for recovery, building a business that performs at flat volumes. Constantly evaluating each business's mission in portfolio.
Calendar 2025 Q4
You seem to call out normalization to industry growth rates. It seems like you still have some nice marine products that are ramping up
Show response
Morales attributed PMC normalization to difficult comparables (11 consecutive quarters compounding) and project-based business requiring new project wins. No share losses implied. Knavish highlighted marine aftermarket strength (SigmaGlide technology) and Asia new builds.
Calendar 2025 Q3
you've previously quantified some of the industrial share gains at $100 million. I guess, first, is that still tracking to plan?
Show response
Morales emphasized volume leverage on fixed costs as biggest earnings lever. Knavish confirmed $100M all flowing through; additional wins above that being won throughout 2025 for longer-term launch. Won't fully offset H1 2026 macro/refinish headwinds but positions well for midterm.
Calendar 2025 Q2
Aerospace continues to be quite strong over a 2- or 3-year stack. How should we think about growth levels over the next few years
Show response
Knavish bullish on all aerospace segments with CEO-level connections confirming extremely strong forecasts. Just announced new $380M aerospace factory in the U.S. Continued debottlenecking investments. No end in sight to growth trajectory.
Calendar 2025 Q1
Just on the Industrial Coatings subsegment within Industrial, you had positive volumes in the quarter. How meaningful were share gains here? And was there any evidence of some prebuying impact that...
Show response
Knavish emphasized momentum from share gains won throughout 2024 into early 2025 now launching. Growth in China, India, general finishes, and U.S. industrial coatings. Used word 'momentum' repeatedly to characterize the trajectory.
Calendar 2024 Q4
what do you see as some of the catalysts to get consumer confidence off the bottom here
Show response
Knavish cited easing inflation, potential rate cuts, and stabilization after 5 years of decline. Morales noted sequential stabilization from mid-single-digit decline in 2023 to flat in H2 2024.
DOWDow Inc.4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q1
Could you perhaps walk through any impacts of the conflict on maybe the 10% to 15% of non-polyolefin derivatives that are exposed to some of these tightening market dynamics
Show response
Fitterling said MEG biggest impact; Equate's global footprint (Canada/Texas) offsetting Kuwait shutdown. Polypropylene less impacted due to weak downstream demand in autos/appliances. Carter noted silicones/siloxanes seeing price increases from China anti-involution rather than conflict.
Calendar 2025 Q3
can you help quantify the run rate earnings contribution from some of these growth investments?
Show response
Carter said Poly-7 and alkoxylation combined $100-200M annualized; ~$40M delivered in Q3. Fitterling added now ethylene-balanced, capturing full integrated margin.
Calendar 2025 Q2
do you see any need for further portfolio restructuring actions on your JVs?
Show response
Fitterling said equity earnings depressed by same market conditions. Kuwait and Thailand in good shape. Active refinancing work on Sadara with Aramco before grace period ends.
Calendar 2024 Q4
are China oversupply issues getting better or worse into 2025? And with the focus on more downstream specialties, would you anticipate taking any further actions on upstream assets
Show response
Fitterling said improving slowly. Carter added downstream growing above GDP in electronics and personal care, while upstream capacity additions from China 2022-2023 have slowed.
IFFInternational Flavors & Fragrances4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
your current outlook for input cost inflation in the second half and whether or not you're encountering any pricing lag or customer resistance
Show response
DeVeau expects input costs to rise modestly in H2 with Scent most impacted; IFF is implementing customer surcharges with some lag while pushing productivity to protect EBITDA margins.
Calendar 2025 Q4
could you comment on any early interest in the sale? Were there any inbounds prior to the formal process?
Show response
Erik confirmed strong early inbound interest from both strategics and PE, with additional firms expressing interest since formal launch. Proceeds earmarked for share buybacks to offset dilution and debt paydown to maintain sub-3x leverage.
Calendar 2025 Q2
On the divestiture to Bunge, can you walk through the strategic rationale? Any dissynergies that you see and help us size the business from a margin perspective?
Show response
Erik explained the divestiture removes commoditized soy crush, concentrates and lecithin with low single-digit EBITDA margins, improving Food Ingredients margins and enabling focus on differentiated isolated soy protein.
Calendar 2025 Q1
what drove volumes lower in protein solutions and how should we think about the outlook there and overall food ingredient volumes for the year
Show response
Erik detailed protein weakness from lower-value segment softness and production issues now being resolved. Food Ingredients EBITDA margins progressed from 12% to 13.9%.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| APD Air Products | 13 | 15%2 of 13 questions |
| DD DuPont | 9 | 0%none of 9 questions |
| ALB Albemarle Corporation | 7 | 14%1 of 7 questions |
| LYB LyondellBasell | 7 | 29%2 of 7 questions |
| SHW The Sherwin-Williams Company | 7 | 14%1 of 7 questions |
| CTVA Corteva | 6 | 0%none of 6 questions |
| ECL Ecolab | 6 | 17%1 of 6 questions |
| LIN Linde plc | 6 | 0%none of 6 questions |
| PPG PPG Industries | 6 | 0%none of 6 questions |
| DOW Dow Inc. | 4 | 0%none of 4 questions |
- APDAir Products · 13 questions15%2 of 13 questions
- DDDuPont · 9 questions0%none of 9 questions
- ALBAlbemarle Corporation · 7 questions14%1 of 7 questions
- LYBLyondellBasell · 7 questions29%2 of 7 questions
- SHWThe Sherwin-Williams Company · 7 questions14%1 of 7 questions
- CTVACorteva · 6 questions0%none of 6 questions
- ECLEcolab · 6 questions17%1 of 6 questions
- LINLinde plc · 6 questions0%none of 6 questions
- PPGPPG Industries · 6 questions0%none of 6 questions
- DOWDow Inc. · 4 questions0%none of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 2 | 0%none of 2 questions | 1 |
| 2024 Q4 | 10 | 10%1 of 10 questions | 8 |
| 2025 Q1 | 10 | 20%2 of 10 questions | 8 |
| 2025 Q2 | 10 | 10%1 of 10 questions | 9 |
| 2025 Q3 | 11 | 9%1 of 11 questions | 9 |
| 2025 Q4 | 9 | 0%none of 9 questions | 8 |
| 2026 Q1 | 14 | 14%2 of 14 questions | 10 |
| 2026 Q2 | 9 | 0%none of 9 questions | 9 |
- 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2024 Q410 questions · challenge rate 10% (1 of 10 questions) · 8 companies
- 2025 Q110 questions · challenge rate 20% (2 of 10 questions) · 8 companies
- 2025 Q210 questions · challenge rate 10% (1 of 10 questions) · 9 companies
- 2025 Q311 questions · challenge rate 9% (1 of 11 questions) · 9 companies
- 2025 Q49 questions · challenge rate 0% (none of 9 questions) · 8 companies
- 2026 Q114 questions · challenge rate 14% (2 of 14 questions) · 10 companies
- 2026 Q29 questions · challenge rate 0% (none of 9 questions) · 9 companies
Topics
Topics tagged on this analyst’s questions.
- Demand25
- Margin20
- Competitive Dynamics18
- Capex Investment16
- Capital Allocation8
- Pricing8
- Supply Chain7
- Innovation & R&D7
- Regulation Policy6
- Revenue Growth6
Show all 20 topics
- Cost Pressure5
- Macroeconomic5
- M&A5
- Trade Tariffs3
- Geographic Expansion2
- Guidance Reliability1
- Inventory1
- Credit1
- Product Launch1
- Cloud & AI1